Reversal of Experimental Diabetic Neuropathy by VEGF Gene Transfer

Journal of Clinical Investigation - United States
doi 10.1172/jci12188
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Neutralization of Schwann Cell-Secreted VEGF Is Protective to in Vitro and in Vivo Experimental Diabetic Neuropathy

PLoS ONE
Multidisciplinary
2014English

Diabetic Neuropathy Collection: Treatment of Diabetic Neuropathy

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Reversal of Albuminuria by Combined Am6545 and Perindopril Therapy in Experimental Diabetic Nephropathy

British Journal of Pharmacology
Pharmacology
2018English

PGC-1α Regulation of Mitochondrial Degeneration in Experimental Diabetic Neuropathy

Neurobiology of Disease
Neurology
2014English

Therapeutic Efficacy of Sonic Hedgehog Protein in Experimental Diabetic Neuropathy

Journal of Clinical Investigation
Medicine
2003English

Reversal of the Symptoms of Diabetic Neuropathy Through Correction of Vitamin D Deficiency in a Type 1 Diabetic Patient

Case Reports in Endocrinology
EndocrinologyMetabolismDiabetes
2012English

Diabetic Neuropathy

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
1954English

Erythropoietin Both Protects From and Reverses Experimental Diabetic Neuropathy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

Association of VEGF Gene Polymorphisms With Diabetic Retinopathy: A Meta-Analysis

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy